The effect of carbohydrate intake on glycaemic control in individuals with type 1 diabetes: a randomised, open-label, crossover trial

被引:0
|
作者
Isaksson, Sterner [1 ,2 ]
Olafsdottir, Arndis F. [1 ,2 ,3 ]
Ivarsson, Simon [2 ]
Imberg, Henrik [4 ,5 ,6 ]
Toft, Eva [7 ,8 ]
Hallstrom, Sara [1 ,3 ]
Rosenqvist, Ulf [9 ]
Ekstrom, Marie [2 ]
Lind, Marcus [1 ,2 ,3 ,6 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden
[2] NU Hosp Grp, Dept Med, Uddevalla, Sweden
[3] Sahlgrens Univ Hosp, Dept Med, Gothenburg, Sweden
[4] Stat Konsultgrp, Gothenburg, Sweden
[5] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden
[6] Univ Gothenburg, Gothenburg, Sweden
[7] Ersta Hosp, Dept Med, Stockholm, Sweden
[8] Karolinska Inst, Dept Clin Educ & Sci, Sodersjukhuset, Stockholm, Sweden
[9] Motala Hosp, Dept Internal Med, Motala, Sweden
来源
LANCET REGIONAL HEALTH-EUROPE | 2024年 / 37卷
关键词
Type 1 diabetes mellitus; Glycaemic control; Continuous glucose monitoring; Medical nutrition therapy; Carbohydrates; ADULTS; DIET; THERAPY;
D O I
10.1016/j.lanepe.2023.100823
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Few studies have examined the effects of lower carbohydrate diets on glucose control in persons with type 1 diabetes (T1D). The objective of the study was to investigate whether a moderate carbohydrate diet improves glucose control in persons with T1D. Methods A randomised, multicentre, open -label, crossover trial over 12 weeks. There were 69 individuals assessed for eligibility, 54 adults with T1D and HbA1c >= 58 mmol/mol (7.5%) were randomised. Interventions were moderate carbohydrate diet versus traditional diet (30 vs 50% of total energy from carbohydrates) over four weeks, with a four -week wash -out period between treatments. Masked continuous glucose monitoring was used to evaluate effects on glucose control. The primary endpoint was the difference in mean glucose levels between the last 14 days of each diet phase. Findings 50 individuals were included in the full analysis set with a mean baseline HbA1c of 69 mmol/mol (8.4%), BMI 29 kg/m2, age of 48 years, and 50% were female. The difference in mean glucose levels between moderate carbohydrate and traditional diet was -0.6 mmol/L, 95% CI -0.9 to -0.3, p < 0.001. Time in range increased during moderate carbohydrate diet by 4.7% (68 min/24 h) (95% CI 1.3 to 8.0), p = 0.008. Time above range (>10 mmol/L) decreased by 5.9% (85 min/24 h), 95% CI -9.6 to -2.2, p = 0.003. There were no significant differences in the standard deviation of glucose levels (95% CI -0.3 to 0.0 mmol/L, p = 0.15) or hypoglycaemia in the range <3.9 mmol/ L (95% CI -0.4 to 2.9%, p = 0.13) and <3.0 mmol/L (95% CI -0.4 to 1.6%, p = 0.26). Four participants withdrew, none because of adverse events. There were no serious adverse events including severe hypoglycaemia and ketoacidosis. Mean ketone levels were 0.17 (SD 0.14) mmol/L during traditional and 0.18 (SD 0.13) mmol/L during moderate carbohydrate diet (p = 0.02). Interpretation A moderate carbohydrate diet is associated with decreases in mean glucose levels and time above range and increases in time in range without increased risk of hypoglycaemia or ketoacidosis compared with a traditional diet in individuals with T1D. Funding The Healthcare Board, Region Vastra Gotaland, The Dr P Hakansson Foundation and the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement [ALFGBG966173]. Copyright (c) 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trial
    Davidsen, Line
    Cichosz, Simon Lebech
    Staehr, Peter Bisgaard
    Vestergaard, Peter
    Drewes, Asbjorn M.
    Knop, Filip Krag
    Jensen, Morten Hasselstrom
    Olesen, Soren Schou
    DIABETES OBESITY & METABOLISM, 2025, : 3379 - 3388
  • [2] Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial
    Ranjan, Ajenthen
    Schmidt, Signe
    Damm-Frydenberg, Camilla
    Holst, Jens Juul
    Madsbad, Sten
    Norgaard, Kirsten
    DIABETES OBESITY & METABOLISM, 2017, 19 (10) : 1479 - 1484
  • [3] Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
    van Beers, Cornelis A. J.
    DeVries, J. Hans
    Kleijer, Susanne J.
    Smits, Mark M.
    Geelhoed-Duijvestijn, Petronella H.
    Kramer, Mark H. H.
    Diamant, Michaela
    Snoek, Frank J.
    Serne, Erik H.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (11) : 893 - 902
  • [4] Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial
    Haidar, Ahmad
    Legault, Laurent
    Messier, Virginie
    Mitre, Tina Maria
    Leroux, Catherine
    Rabasa-Lhoret, Remi
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (01) : 17 - 26
  • [5] Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial
    Lane, Wendy S.
    Weinrib, Stephen L.
    Lawrence, Michael J.
    Lane, Benjamin C.
    Jarrett, Ryan T.
    ENDOCRINE PRACTICE, 2022, 28 (02) : 165 - 172
  • [6] A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial
    Tsoukas, Michael A.
    Majdpour, Dorsa
    Yale, Jean-Francois
    El Fathi, Anas
    Garfield, Natasha
    Rutkowski, Joanna
    Rene, Jennifer
    Legault, Laurent
    Haidar, Ahmad
    LANCET DIGITAL HEALTH, 2021, 3 (11): : E723 - E732
  • [7] Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover study
    Schmidt, Signe
    Christensen, Merete B.
    Serifovski, Nermin
    Damm-Frydenberg, Camilla
    Jensen, Jens-Erik B.
    Floyel, Tina
    Storling, Joachim
    Ranjan, Ajenthen
    Norgaard, Kirsten
    DIABETES OBESITY & METABOLISM, 2019, 21 (07) : 1680 - 1688
  • [8] Usage of glucometer is associated with improved glycaemic control in type 2 diabetes mellitus patients in Malaysian public primary care clinics: an open-label, randomised controlled trial
    Ismail, Mastura
    Teng, Chong-Lieng
    Omar, Mimi
    Ho, Bee Kiau
    Kusiar, Zainab
    Hasim, Ruziaton
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (07) : 391 - 395
  • [9] Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial
    Thomsen, Mads N.
    Skytte, Mads J.
    Samkani, Amirsalar
    Carl, Martin H.
    Weber, Philip
    Astrup, Arne
    Chabanova, Elizaveta
    Fenger, Mogens
    Frystyk, Jan
    Hartmann, Bolette
    Holst, Jens J.
    Larsen, Thomas M.
    Madsbad, Sten
    Magkos, Faidon
    Thomsen, Henrik S.
    Haugaard, Steen B.
    Krarup, Thure
    DIABETOLOGIA, 2022, 65 (03) : 506 - 517
  • [10] Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1 diabetes
    Isaksson, Sofia Sterner
    Olafsdottir, Arndis F.
    Lind, Marcus
    FRONTIERS IN NUTRITION, 2023, 10